Pricing Log in Create free account

CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) vs Alaunos Therapeutics, Inc. (TCRT)

CollPlant Biotechnologies Ltd. Sponsored ADR and Alaunos Therapeutics, Inc. are both Biotechnology companies. CollPlant Biotechnologies Ltd. Sponsored ADR and Alaunos Therapeutics, Inc. are of similar size ($7.6M and $7.5M). Alaunos Therapeutics, Inc. grew revenue faster over the last twelve months: −17.7% against −86.8%. Alaunos Therapeutics, Inc. has the higher net margin (0.00% vs −3,934.9%) and the lower return on invested capital (−480.4% vs 0.00%). Across the 17 metrics below, CollPlant Biotechnologies Ltd. Sponsored ADR leads on 9 and Alaunos Therapeutics, Inc. on 8.

Valuation

Metric CLGN TCRT Biotechnology median
P/E n/m n/m 10.26
P/S 18.24 314.42 9.18
P/B 1.97 6.75 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 26.12 1,409.85 8.98
Earnings yield (235.64%) (106.78%) (34.89%)
Free cash flow yield (193.83%) (30.01%) (24.52%)

Profitability

Metric CLGN TCRT Biotechnology median
Gross margin (321.70%) 100.00% 65.16%
Operating margin (3,900.94%) 0.00% 0.00%
Net margin (3,934.91%) 0.00% 0.00%
Free cash flow margin (3,522.64%) 0.00% 0.00%
Return on equity (161.98%) (185.95%) (50.12%)
Return on assets (101.59%) (128.30%) (45.60%)
Return on invested capital 0.00% (480.35%) 0.00%

Growth

Metric CLGN TCRT Biotechnology median
Revenue growth (TTM) (86.76%) (17.65%) 6.26%
EPS growth (last fiscal year) 35.17% 24.66% 29.88%
Revenue growth, 5-year CAGR (17.32%) (49.08%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLGN TCRT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.57 0.77 4.89
Net debt to EBITDA 0.56 0.33 1.01

Dividend

Metric CLGN TCRT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLGN TCRT Biotechnology median
Market cap 7.45m 7.60m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack